Literature DB >> 19479978

Macroscopic assessment of mesorectal excision in rectal cancer: a useful tool for improving quality control in a multidisciplinary team.

Eduardo García-Granero1, Omar Faiz, Elena Muñoz, Blas Flor, Samuel Navarro, Carmen Faus, Stephannie Anne García-Botello, Salvador Lledó, Andrés Cervantes.   

Abstract

BACKGROUND: High quality of surgical technique and the use of descriptive measures to assess and report surgical proficiency have been shown to influence locoregional tumor control in patients with rectal cancer. In this study, the authors have aimed to audit the implementation of a macroscopic assessment of mesorectal excision (MAME) and to investigate factors that influenced surgical quality and disease recurrence.
METHODS: All curative resections for rectal cancer were prospectively evaluated for MAME between 1998 and 2007. Mesorectal specimens were graded into 3 types: complete, nearly complete, and incomplete categories. Univariate and multivariate analyses identified independent risk factors for noncomplete mesorectum categories as well as local and overall tumor recurrence.
RESULTS: Of 359 specimens, 294 (81.9%) underwent evaluation; 82.3% were "complete." Abdominoperineal resection (APR) was the sole covariate associated with inadequate mesorectal excision (odds ratio [OR]=2.7; P=.003). Independent predictors of local recurrence were circumferential resection margin (CRM) involvement (OR=3.6; P=.027) and noncomplete mesorectum (OR=4.4; P=.008). CRM+ (OR=3.1; P=.004), poorly differentiated tumors (OR=14.2; P=.010), nodal involvement (OR=2.9; P=.010), and APR (OR=2.9; P=.006) were independent risk factors for overall recurrence. In lower third tumors, noncomplete mesorectum occurred more frequently in APR compared with sphincter-saving procedures (31.1% vs 18.8%; P=.088).
CONCLUSIONS: This study demonstrates the value of auditing MAME. Good proficiency of mesorectal excision is associated with lower tumor recurrences after curative surgery, and is a morphological tool found to be useful in clinical practice. Copyright (c) 2009 American Cancer Society.

Entities:  

Mesh:

Year:  2009        PMID: 19479978     DOI: 10.1002/cncr.24387

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  17 in total

Review 1.  Update on the surgical pathology standards on rectal cancer diagnosis, staging and quality assessment of surgery.

Authors:  Alejandro Rojo; Pilar Sancho; Oscar Alonso; Sara Encinas; Gemma Toledo; Juan F García
Journal:  Clin Transl Oncol       Date:  2010-06       Impact factor: 3.405

2.  Laparoscopic-assisted abdominoperineal resection for low rectal cancer provides a shorter length of hospital stay while not affecting the recurrence or survival: a propensity score-matched analysis.

Authors:  Manfred Odermatt; Karen Flashman; Jim Khan; Amjad Parvaiz
Journal:  Surg Today       Date:  2015-09-05       Impact factor: 2.549

3.  Predicting the pathological features of the mesorectum before the laparoscopic approach to rectal cancer.

Authors:  Sonia Fernández Ananín; Eduardo M Targarona; Carmen Martinez; Juan Carlos Pernas; Diana Hernández; Ignasi Gich; Francesc J Sancho; Manuel Trias
Journal:  Surg Endosc       Date:  2014-06-21       Impact factor: 4.584

Review 4.  EURECCA consensus conference highlights about colorectal cancer clinical management: the pathologists expert review.

Authors:  P Quirke; N P West; I D Nagtegaal
Journal:  Virchows Arch       Date:  2014-01-24       Impact factor: 4.064

5.  Multicentre propensity score-matched analysis of laparoscopic versus open surgery for T4 rectal cancer.

Authors:  Nicola de'Angelis; Filippo Landi; Giulio Cesare Vitali; Riccardo Memeo; Aleix Martínez-Pérez; Alejandro Solis; Michela Assalino; Francesc Vallribera; Henry Alexis Mercoli; Jacques Marescaux; Didier Mutter; Frédéric Ris; Eloy Espin; Francesco Brunetti
Journal:  Surg Endosc       Date:  2016-11-08       Impact factor: 4.584

Review 6.  Extended abdominoperineal excision vs. standard abdominoperineal excision in rectal cancer--a systematic overview.

Authors:  Sigmar Stelzner; Carsta Koehler; Juliane Stelzer; Anja Sims; Helmut Witzigmann
Journal:  Int J Colorectal Dis       Date:  2011-05-21       Impact factor: 2.571

Review 7.  The role of the pathologist in rectal cancer diagnosis and staging and surgical quality assessment.

Authors:  Carmen Faus; Desamparados Roda; Matteo Frasson; Susana Roselló; Eduardo García-Granero; Blas Flor-Lorente; Samuel Navarro
Journal:  Clin Transl Oncol       Date:  2010-05       Impact factor: 3.405

8.  Completeness of operative reports for rectal cancer surgery.

Authors:  Arielle E Kanters; Joceline V Vu; Ari D Schuman; Inga Van Wieren; Ashley Duby; Karin M Hardiman; Samantha K Hendren
Journal:  Am J Surg       Date:  2019-09-28       Impact factor: 2.565

9.  Transanal natural orifice specimen extraction for laparoscopic anterior resection in rectal cancer.

Authors:  Fang-Hai Han; Li-Xin Hua; Zhi Zhao; Jian-Hai Wu; Wen-Hua Zhan
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

Review 10.  Pathologic processing of the total mesorectal excision.

Authors:  Molly Campa-Thompson; Robert Weir; Natalie Calcetera; Philip Quirke; Susanne Carmack
Journal:  Clin Colon Rectal Surg       Date:  2015-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.